NCT03418389View on ClinicalTrials.gov

Evaluate and Monitor Physical Performance of Adults Treated With Asfotase Alfa for Hypophosphatasia

CompletedOBSERVATIONAL
Enrollment

23

Participants

Timeline

Start Date

September 5, 2018

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions
Hypophosphatasia
Trial Locations (1)

97074

Clinical Trial Unit, Orthopedic Department, Wuerzburg University, Würzburg

Sponsors
All Listed Sponsors
collaborator

Alexion Pharmaceuticals, Inc.

INDUSTRY

lead

Dr. Lothar Seefried

OTHER